Euclidean Capital LLC
CIK: 0001825034Latest portfolio: $369.4M · Q4 2025
Holdings
12
Total Value
$369.4M
New Positions
1
Closed Positions
0
Top Holdings
| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | VEUVANGUARD INTL EQUITY INDEX F | 2,990,084 | $219.9M | 59.53% | +412K | |
| 2 | VTVVANGUARD INDEX FDS | 520,000 | $99.3M | 26.88% | NEW | |
| 3 | INDAISHARES TR | 369,600 | $20.0M | 5.41% | — | |
| 4 | FHTXFOGHORN THERAPEUTICS INC | 1,573,761 | $8.5M | 2.30% | — | |
| 5 | ORICORIC PHARMACEUTICALS INC | 989,410 | $8.1M | 2.19% | — | |
| 6 | PMVPPMV PHARMACEUTICALS INC | 2,627,643 | $3.3M | 0.89% | — | |
| 7 | SPYSPDR S&P 500 ETF TR | 4,104 | $2.8M | 0.76% | — | |
| 8 | RAPTRAPT THERAPEUTICS INC | 82,234 | $2.8M | 0.75% | — | |
| 9 | ALECALECTOR INC | 1,307,858 | $2.0M | 0.55% | — | |
| 10 | SRZNSURROZEN INC | 87,696 | $2.0M | 0.54% | — | |
| 11 | TNYATENAYA THERAPEUTICS INC | 1,015,705 | $722K | 0.20% | — | |
| 12 | SRZNWSURROZEN INC | 170,833 | $3K | 0.00% | — |
Quarterly Changes
New Positions
- VTVNEW$99.3M
Closed Positions
No closed positions this quarter
Increased Positions
| Name | Shares | Change |
|---|---|---|
| VEU | 3.0M | +412K |
Decreased Positions
No decreased positions
Sector Breakdown
Healthcare0.0% ($8498809332842784768.0T)
Financial Services0.0% ($21995099314.2T)
Filing History
Fund Information
Euclidean Capital LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $369.4M across 12 holdings. The largest position is VANGUARD INTL EQUITY INDEX F (VEU), representing 59.5% of the portfolio. Compared to the previous quarter, the fund opened 1 new positions and closed 0 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.